Morinaga Milk FY26 Net Profit Quadruples to ¥22.6 Billion as Overseas Whey and Probiotics Drive Margin Expansion

Morinaga Milk Industry Co., Ltd. (TSE Prime: 2264), one of Japan's leading dairy and nutritional food groups, released consolidated full-year results for the fiscal year ended March 31, 2026 (FY3/2026) under Japanese GAAP. Net sales reached ¥571,458 million (+1.8% YoY) and operating profit climbed 16.3% to ¥34,479 million; ordinary profit rose 24.3% to ¥37,121 million. The headline figure was profit attributable to owners of the parent, which surged 313.9% to ¥22,599 million from ¥5,459 million a year earlier, lifting basic EPS to ¥276.02 from ¥64.60. Operating margin expanded to 6.0% from 5.3%, ROE rebounded to 8.4% from 2.0%, and ROIC improved to 6.3% from 5.7%.

Overseas business is the standout driver

Within the reportable Food segment (net sales ¥547,661 million, +1.8%; segment profit ¥45,807 million, +15.1%), management's strategic domain framework tells the clearest story. The Core Domain (whey ingredients, cheese, beverages, clinical nutrition) expanded sales 3.4% to ¥364,964 million with operating profit up ¥6,335 million to ¥20,033 million, propelled by Germany-based subsidiary MILEI GmbH, which benefited from sustained high global whey protein prices and higher volumes. The Growth Domain (yogurt, ice cream, probiotic cultures, overseas infant formula) lifted sales 5.2% to ¥124,529 million but operating profit fell ¥1,183 million to ¥12,591 million, weighed down by raw-material inflation and new ice-cream capacity depreciation. The Cultivation/Other Domain saw sales decline 8.8% to ¥81,965 million.

Overseas in aggregate posted a 25.1% sales jump to ¥87,474 million, with operating profit surging ¥9,521 million to ¥16,997 million on MILEI, overseas probiotic and infant-formula growth, contributions from Pakistan's NutriCo Morinaga, US subsidiary plant integration benefits, and reduced goodwill amortization. The overseas sales ratio rose to 15.3% from 12.5%, already meeting the FY3/2029 mid-term target. Domestically, results were pressured by elevated raw-milk prices (lifted from June and August 2025), higher logistics, energy and labor costs, and softer consumer demand, partly mitigated by price revisions and high-value-added yogurt and ice-cream expansion.

Lower impairments drive the bottom-line swing

The dramatic year-on-year profit growth reflects extraordinary items more than operations. Extraordinary losses fell to ¥7,805 million from ¥25,826 million, with impairment losses dropping to ¥3,553 million from ¥20,483 million. Other special items included ¥1,667 million of contributions to the Hikari Association (arsenic-tainted milk incident victim support), ¥645 million of fixed-asset disposal losses, ¥572 million of plant reorganization costs and ¥509 million of rebuilding-related losses. Extraordinary gains totaled ¥2,922 million, headlined by a ¥2,215 million gain on termination of a retirement benefit plan. Total assets rose ¥26,693 million to ¥547,116 million on capacity expansion; net assets grew to ¥279,749 million with an equity ratio of 50.2%. Operating cash flow rebounded sharply to a ¥35,716 million inflow from a ¥12,456 million outflow, while investing activities used ¥38,870 million primarily for fixed assets.

Dividend lifted, 1-for-4 split coming in July 2026

The FY3/2026 annual dividend was raised to ¥100.00 per share (¥45 interim + ¥55 year-end) from ¥90.00, implying a 36.2% consolidated payout ratio. For FY3/2027, guidance is ¥25.00 on a post-split basis (equivalent to ¥100 pre-split) incorporating a 1-for-4 stock split effective July 1, 2026, designed to broaden the investor base. The payout-ratio target has been raised to 40%. Full-year FY3/2027 guidance calls for net sales of ¥580,000 million (+1.5%), operating profit of ¥32,000 million (-7.2%), and net profit attributable to owners of ¥20,000 million (-11.5%), reflecting an estimated ¥4 billion negative operating-profit impact through September from Middle East tensions, a MILEI reaction decline after exceptional FY3/2026 inventory-driven volumes, and continued cost pressures. Separately, on March 13, 2026 the company announced a basic policy to absorb wholly-owned subsidiary Morinaga Milk Industry Sales Co., Ltd. via a simplified merger effective April 2027.

JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.